These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22586898)

  • 1. [Efficacy of enterocin S760 in treatment of mice with anthrax infection due to Bacillus anthracis M-71].
    Svetoch EA; Borzilov AI; Eruslanov BV; Korobova OV; Kombarova TI; Levchuk VP; Teĭmurazov MG; Stepanshin IuG; Marinin LI; Diatlov IA
    Antibiot Khimioter; 2011; 56(9-10):13-8. PubMed ID: 22586898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial activity of bacteriocin S760 produced by Enterococcus faecium strain LWP760].
    Svetoch ÉA; Eruslanov BV; Levchuk VP; Mitsevich EV; Mitsevich IP; Kovalev IuN; Fursova NK; Teĭmurazov MG; Stepanshin IuG; Volodina LI; Diatlov IA
    Antibiot Khimioter; 2011; 56(1-2):3-9. PubMed ID: 21780664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of enterocin S760 for prevention and treatment of experimental Salmonella infection in mice].
    Svetoch EA; Borzilov AI; Eruslanov BV; Korobova OV; Teĭmurazov MG; Kombarova TI; Diatlov IA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):44-8. PubMed ID: 21061577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.
    Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP
    Antimicrob Agents Chemother; 2010 Mar; 54(3):991-6. PubMed ID: 20047912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Heine HS; Bassett J; Miller L; Bassett A; Ivins BE; Lehoux D; Arhin FF; Parr TR; Moeck G
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3350-7. PubMed ID: 18606841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid
    Lawrence WS; Peel JE; Slayden RA; Peterson JW; Baze WB; Hensel ME; Whorton EB; Beasley DWC; Cummings JE; Macias-Perez I
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0011224. PubMed ID: 38888319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
    Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice.
    Elliott TB; Brook I; Harding RA; Bouhaouala SS; Shoemaker MO; Knudson GB
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3463-71. PubMed ID: 12384351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Efficacy of FDA-Approved
    Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.
    Otvos L; Flick-Smith H; Fox M; Ostorhazi E; Dawson RM; Wade JD
    Protein Pept Lett; 2014 Apr; 21(4):374-81. PubMed ID: 24164262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of
    Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D
    J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?
    Antoniu SA
    Expert Opin Investig Drugs; 2010 Jul; 19(7):909-11. PubMed ID: 20450444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
    Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS
    Antimicrob Agents Chemother; 2010 May; 54(5):1678-83. PubMed ID: 20145081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus anthracis and antibacterial agents.
    Bryskier A
    Clin Microbiol Infect; 2002 Aug; 8(8):467-78. PubMed ID: 12197869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
    Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4471-3. PubMed ID: 20643899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.
    Ishibashi N; Himeno K; Fujita K; Masuda Y; Perez RH; Zendo T; Wilaipun P; Leelawatcharamas V; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2012; 76(5):947-53. PubMed ID: 22738965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Bacillus anthracis in an endemic area.
    Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M
    Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis.
    Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H
    PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax-protective effects of yeast beta 1,3 glucans.
    Kournikakis B; Mandeville R; Brousseau P; Ostroff G
    MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.